Oncogenic osteomalacia: Clinical Trials

2 trials for Oncogenic osteomalacia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated, 1 unknown. 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 12Terminated 1, Unknown 1

Follow Oncogenic osteomalacia: new trials by email Literature Review of Oncogenic osteomalacia trials Research Report on Oncogenic osteomalacia

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Application of 68Ga-DOTA-TATE and 68Ga-DOTA-JR11 PET/CT in the Diagnosis and Evaluation of TIO
68Ga-Dotatate, 68Ga-DOTA-JR11 - Tumor-Induced Osteomalacia
Phase 1UnknownPeking Union Medical College Hospital502020-03-152021-01-05
Cinacalcet for Fibroblast Growth Factor 23 (FGF23)-Mediated Hypophosphatemia (Hypophosphatemic Rickets)
Osteomalacia - Osteomalacia
Phase 1TerminatedNational Institute of Dental and Craniofacial Research (NIDCR)12012-11-162018-07-05

Narrower conditions

Osteomalacia (1)  ·  Rickets, Hypophosphatemic (1)

Broader conditions

Avitaminosis (1)  ·  Bone Diseases (1)  ·  Bone Diseases, Metabolic (1)  ·  Calcium Metabolism Disorders (1)  ·  Deficiency Diseases (1)  ·  Hypophosphatemia (1)  ·  Malnutrition (1)  ·  Metabolic Diseases (1)  ·  Musculoskeletal Diseases (1)  ·  Nutrition Disorders (1)  ·  Nutritional and Metabolic Diseases (1)  ·  Phosphorus Metabolism Disorders (1)  ·  Rickets (1)  ·  Vitamin D Deficiency (1)

Interventions

gallium Ga 68 dotatate (1)

Sponsors

National Institute of Dental and Craniofacial Research (NIDCR) (1)  ·  Peking Union Medical College Hospital (1)

Countries

China (1)  ·  United States (1)

Top investigators

Hongli Jing, MD (1)  ·  Rachel I Gafni, M.D. (1)

Results publications

PMID 35280786